Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia

American Journal of Pathology

Volumn 153, Issue 2, 1998, Pages 527-535

  Ramm, Grant A ^a   Nair, Visalini G ^a   Bridle, Kim R ^a   Shepherd, Ross W ^b   Crawford, Darrell H G ^a,c  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; COLLAGEN; MESSENGER RNA; PROCOLLAGEN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BILE DUCT ATRESIA; BILE DUCT OBSTRUCTION; CHILD; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; LIVER BIOPSY; LIVER FIBROSIS; LIVER PARENCHYMA; MALE; NEWBORN; PORTOENTEROSTOMY; PRIORITY JOURNAL; STELLATE CELL;

EID: 0031878097     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65595-2     Document Type: Article

References (57)

1. Balistreri WF: Neonatal cholestasis: medical progress. J Pediatr 1985, 106:171-184
2. Kasai M, Yakovac WC, Koop CE: Liver in congenital biliary atresia and neonatal hepatitis: a histopathological study. Arch Pathol 1962, 74:152-162
3. Kasai M, Suzuki S: A new operation for "non-correctable" biliary atresia: hepatic portoenterostomy. Shujutsu 1959, 13:733-739
4. Kasai M: Treatment of biliary atresia with special reference to hepatic portoenterostomy and its modifications. Prog Pediatr Surg 1974, 6:5-52
5. Otte JB, de Ville de Goyet J, Reding R, Hausleithner V, Sokal E, Chardot C, Debande B: Sequential treatment of biliary atresia with Kasai portoenterostomy, and liver transplantation: a review. Hepatology 1994, 20(Suppl):41S-48S
6. Balistreri WF, Grand R, Hoofnagle JH, Suchy FJ, Ryckman FC, Perlmutter DH, Sokol RJ: Biliary atresia: current concepts and research directions. Hepatology 1996, 23:1682-1692
7. Kasai M, Mochizuki I, Ohkohchi N, Chiba T, Ohi R: Surgical limitations for biliary atresia: indications for liver transplantation. J Pediatr Surg 1989, 24:851-854
8. Laurent J, Gauthier F, Bernard O, Hadchouel M, Odievre M, Valayer J, Alagille D: Long-term outcome after surgery for biliary atresia: study of 40 patients surviving for more than 10 years. Gastroenterology 1990, 99:1793-1797
9. Stein JE, Vacanti JP: Biliary atresia and other disorders of the extrahepatic biliary tree. Liver Disease in Children. Edited by FJ Suchy. St. Louis, Mosby, 1994, pp 426-442
10. Shepherd RW: Liver transplantation in children. Med J Aust 1990, 153:509-510
11. Lynch SV, Akiyama T, Ong TH, Pillay SP, Balderson GA, Matsunami H, Shepherd RW, Cleghorn GJ, Patrick MK, Strong RW: Transplantation in children with biliary atresia. Transplant Proc 1992, 24:186-188
12. Ramm GA, Crawford DHG, Powell LW, Walker NI, Fletcher LM, Halliday JW: Hepatic stellate cell activation in genetic hemochromatosis: lobular distribution, effect of increasing hepatic iron and response to phlebotomy. J Hepatol 1997, 26:584-592
13. Minato Y, Hasumura Y, Takeuchi J: The role of fat-storing cells in Disse space fibrogenesis in alcoholic liver disease. Hepatology 1983, 3:559-566
14. Friedman SL: Hepatic stellate cells. Prog Liver Dis 1996, 14:101-130
15. Ramm GA, Li SCY, Li L, Britton RS, O'Neill R, Kobayashi Y, Bacon BR: Chronic iron overload causes in vivo activation of rat lipocytes. Am J Physiol 1995, 268:G451-G458
16. Pietrangelo A, Gualdi R, Casalgrandi G, Geerts A, De Bleser P, Montosi G, Ventura E: Enhanced hepatic collagen type I mRNA expression into fat-storing cells in a rodent model of hemochromatosis. Hepatology 1994, 19:714-721
17. Rockey DC, Housset CN, Friedman SL: Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo. J Clin Invest 1993, 92:1795-1804
18. 4-or vitamin A-treated rats. Dig Dis Sci 1987, 32:1281-1289
19. Takahara T, Kojima T, Miyabayashi C, Inoue K, Sasaki H, Muragaki Y, Ooshima A: Collagen production in fat-storing cells after carbon tetrachloride intoxication in the rat: immunoelectron microscopic observation of type I, type III collagens, and prolyl hydroxylase. Lab Invest 1988, 59:509-521
20. Matsuoka M, Zhang MY, Tsukamoto H: Sensitization of hepatic lipocytes by high-fat diet to stimulatory effects of Kupffer cell-derived factors: implication in alcoholic liver fibrogenesis. Hepatology 1990, 11:173-182
21. Maher JJ, McGuire RF: Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. J Clin Invest 1990, 86:1641-1648
22. Hines JE, Johnson SJ, Burt AD: In vivo responses of macrophages, and perisinusoidal cells to cholestatic liver injury. Am J Pathol 1993, 142:511-518
23. Ramm GA, Crawford DHG, Bridle KR, Britton RS, Bacon BR, Tracy TF Jr: Biliary decompression results in rapid reversal of procollagen α1(I) mRNA gene expression in experimental biliary fibrosis. Hepatology 1996, 24:A463
24. Olynyk JK, Yeoh GC, Ramm GA, Clarke SL, Hall PM, Britton RS, Bacon BR, Tracy TF: Gadolinium chloride suppresses hepatic oval cell proliferation in rats with biliary obstruction. Am J Pathol 1998, 152:347-352
25. Friedman SL: The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993, 328:1828-1835
26. Friedman SL, Yamasaki G, Wong L: Modulation of transforming growth factor-β receptors of rat lipocytes during the hepatic wound healing response: enhanced binding and reduced gene expression accompany cellular activation in culture and in vivo. J Biol Chem 1994, 269:10551-10558
27. Armendariz-Borunda J, Simkevich CP, Roy N, Raghow R, Kang AH, Seyer JM: Activation of Ito cells involves regulation of AP-1 binding proteins and induction of type I collagen gene expression. Biochem J 1994, 304:817-824
28. Rippe RA, Almounajed G, Brenner DA: Sp-1 binding activity increases in activated Ito cells. Hepatology 1995, 251:241-251
29. Koop CE: Biliary obstruction in the newborn. Surg Clin North Am 1976, 56:373-377
30. Rex M, Scotting PJ: Simultaneous detection of RNA and protein in tissue sections by nonradioactive in situ hybridization followed by immunohistochemistry. Biochemica 1994, 3:24-26
31. Ooi LLPJ, Crawford DHG, Gotley DC, Clouston AD, Strong RW, Gobé GC, Halliday JW, Bridle KR, Ramm GA: Evidence that "myofibroblast-like" cells are the cellular source of capsular collagen in hepatocellular carcinoma. J Hepatol 1997, 26:798-807
32. Middlesworth W, Altman RP: Biliary atresia. Curr Opin Pediatr 1997, 9265-269
33. Malizia G, Brunt EM, Peters MG, Rizzo A, Broekelmann TJ, McDonald JA: Growth factor and procollagen type I gene expression in human liver disease. Gastroenterology 1995, 108:145-156
34. Tsutsumi M, Takada A, Takase S: Characterization of desmin-positive rat liver sinusoidal cells. Hepatology 1987, 7:277-284
35. Haruna Y, Saito K, Spaulding S, Nalesnik MA, Gerber MA: Identification of bipotential progenitor cells in human liver development. Hepatology 1996, 23:476-481
36. Friedman SL, Rockey DC, McGuire RF, Maher JJ, Boyles JK, Yamasaki G: Isolated hepatic lipocytes and Kupffer cells from normal human liver: morphological and functional characteristics in primary culture. Hepatology 1992, 15:234-243
37. Schmitt-Graff A, Kruger A, Bochard F, Gabbiani G, Denk H: Modulation of α smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human liver. Am J Pathol 1991, 138:1233-1242
38. Geerts A, De Bleser P, Hautekeete ML, Niki T, Wisse E: Fat-storing (Ito) cell biology. The Liver: Biology and Pathobiology. Edited by IM Arias, JL Boyer, N Fausto, WB Jakoby, D Schachter, DA Shafritz. New York, Raven, 1994, pp 819-838
39. McEvoy CF, Suchy FJ: Biliary tract disease in children. Pediatr Clin North Am 1996, 43:75-98
40. Milani S, Herbst H, Schuppan D, Stein H, Surrenti C: Transforming growth factors β 1 and β 2 are differentially expressed in fibrotic liver disease. Am J Pathol 1991, 139:1221-1229
41. Saperstein LA, Jirtle RL, Farouk M, Thompson HJ, Chung KS, Meyers WC: Transforming growth factor-beta 1, and mannose 6-phosphate/ insulin-like growth factor-II receptor expression during intrahepatic bile duct hyperplasia and biliary fibrosis in the rat. Hepatology 1994, 19:412-417
42. 1 peptide immunolocalization in biliary atresia: comparison with the normal pattern in the developing human intrahepatic bile duct system. Pathol Int 1995, 45:815-824
43. Tracy TF Jr, Dillon P, Fox ES, Minnick K, Vogler C: The inflammatory response in pediatric biliary disease: macrophage phenotype and distribution. J Pediatr Surg 1996, 31:121-126
44. Tracy TF Jr, Fox ES: CD14-lipopolysaccharide receptor activation in hepatic macrophages following cholestatic liver injury. Surgery 1995, 118:371-377
45. Hines JE, Johnston SJ, Burt AD: In vivo responses of macrophages and perisinusoidal cells to cholestatic liver injury. Am J Pathol 1993, 142:511-517
46. Roland CR, Goss JA, Mangino MJ, Hafenrichter D, Flye MW: Autoregulation by eicosanoids of human Kupffer cell secretory products: a study of interleukin-1, interleukin-6, tumor necrosis factor-α, transforming growth factor-β and nitric oxide. Ann Surg 1994, 219:389-399
47. Slott PA, Liu MH, Tavoloni N: Origin, pattern, and mechanism of bile duct proliferation following biliary obstruction in the rat. Gastroenterology 1990, 99:466-477
48. Polimeno L, Azzarone A, Hua Zeng Q, Panella C, Subbotin V, Carr B, Bouzahzah B, Francavilla A, Starzl TE: Cell proliferation and oncogene expression after bile duct ligation in the rat: evidence of a specific growth effect on bile duct cells. Hepatology 1995, 21:1070-1078
49. Tracy TF Jr, Goerke ME, Bailey PV, Sotelo-Avila C, Weber TR: Growth-related gene expression in early cholestatic liver injury. Surgery 1993, 114:532-537
50. Greim H, Trulzsch D, Gzygan P, Rudick J, Hutterer F, Schaffner F, Popper H: Mechanisms of cholestasis: bile acids in human livers with or without biliary obstruction. Gastroenterology 1972, 63:846-850
51. Sokol RJ, Winklhofer-Roob BM, Devereaux MW, McKim JM Jr: Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids. Gastroenterology 1995, 109:1249-1256
52. Hofmann AF, Popper H: Ursodeoxycholic acid for primary biliary cirrhosis. Lancet 1987, 2:398-399
53. Sokol RJ, Devereaux M, Khandwala T, O'Brien K: Evidence for involvement of oxygen free radicals in bile acid toxicity to isolated rat hepatocytes. Hepatology 1993, 17:869-881
54. Patel T, Bronk SF, Gores GJ: Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in hepatocytes. J Clin Invest 1994, 94:2183-2192
55. Spivey JR, Bronk SF, Gores GJ: Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes: role of ATP depletion and cytosolic free calcium. J Clin Invest 1993, 92:17-24
56. Krahenbuhl S, Tabs C, Lauterburg BH, Reichen J: Reduced antioxidative capacity in liver mitochondria from bile duct-ligated rats. Hepatology 1995, 22:607-612
57. Sokol RJ, Devereaux M, Khandwala RA: Effect of dietary lipid and vitamin E on mitochondrial lipid peroxidation and hepatic injury in the bile duct-ligated rat. J Lipid Res 1991, 32:1349-1357